Skip to main content
. 2021 Apr 29;17(7):1851–1863. doi: 10.7150/ijbs.59588

Table 1.

MiRNAs that regulate lipid metabolism in nonalcoholic fatty liver disease (NAFLD).

MiRNA Circulation level Liver expression Function* Identified targets
miR-21 10,11 9,15 FOXA2, FOXO1, HNF4α, STAT3, INSIG2,12 LRP6,13 Hbp1,15 PPARα16,17
miR-122 22,38 2223 25,2827 Agpat1, Dgat1,25 CPEB1,28 Sirt129
miR-34a 10,11 32,30 Sirt1,30,31,36 HNF4α,32 PPARα30
miR-27a 39 40 4041 FAS, SCD1,40 Nrf241
miR-29a 42 43in fibrosis HMGCR,44 DNMT3b,45 CD36,43 GSK3β46
miR-132 unknown 47 FoxO3, PTEN, Sirt1, CYP2E1, P30047
miR-125b 22 48 FAS49
miR-155 unknown 50,51 Ces3/TGH,50 LXα52
miR-192 11,22 53 SREBF1,54 SCD153
miR-378 unknown 55,56 Nrf156

* ↑: aggravating hepatic steatosis; ↓: alleviating hepatic steatosis.